CCP
ARKG icon

Carmel Capital Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Carmel Capital Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-194
Closed -$6.61K – 758
2023
Q2 		$6.61K Hold
194
– – ﹤0.01% 305
2023
Q1 		$5.83K Buy
+194
New +$6.01K ﹤0.01% 358

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $3.3B AUM 33.88% 1-Year Est. Return

Carmel Capital Partners's ARKG Position: Q3 2023 in Review

Carmel Capital Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 194 shares — an estimated $6.61K sold.

Carmel Capital Partners first reported a position in ARKG in Q1 2023 and held it in 2 quarters. The position peaked at $6.61K in Q2 2023. 288 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

  • Carmel Capital Partners reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 194 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $6.61K.
  • Carmel Capital Partners first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 2 quarters.
  • Carmel Capital Partners's ARK Genomic Revolution ETF position peaked at $6.61K in Q2 2023.
  • 288 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Carmel Capital Partners's 13F filing for Q3 2023, filed 27 Oct 2023.